LMT vs VNDA · P/E 20, rev $20.06B vs rev $102.2M
Lockheed Martin Corporation (LMT) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by James D. Taiclet Jr..
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported LMT revenue for 2026-06-28 was $20.06B. Net income was $1.84B. Revenue was up 11.3% from 2026-03-29 to 2026-06-28. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
LMT currently screens at market cap $108.37B and trailing P/E 19.9. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the LMT and VNDA stock pages for the full models.
Not investment advice.